March 12, 2018 / 11:26 AM / 6 months ago

BRIEF-Syros Pharmaceuticals Reports Q4 Loss Per Share $0.58

March 12 (Reuters) - Syros Pharmaceuticals Inc:

* SYROS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND HIGHLIGHTS RECENT ACCOMPLISHMENTS AND ANTICIPATED MILESTONES

* Q4 LOSS PER SHARE $0.58

* Q4 EARNINGS PER SHARE VIEW $-0.57 — THOMSON REUTERS I/B/E/S

* ANNOUNCED APPOINTMENT OF JOSEPH J. FERRA AS CHIEF FINANCIAL OFFICER

* SYROS PHARMA - BELIEVES CASH, CASH EQUIVALENTS AS OF DEC 31, 2017 WILL BE SUFFICIENT TO ENABLE CO TO FUND PLANNED OPERATING EXPENSE, CAPEX INTO 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below